Search All News
CancerFIT—a free exercise program at CUIMC for cancer patients and survivors—offers more than a physical workout, it also provides much-needed support and inspiration.
Columbia biomedical engineers have designed a bacteria strain that seeks out solid tumors and safely delivers immunotherapies, resulting in tumor regression in mouse models.
The three scientists honored by the 2019 Horwitz Prize played key roles in identifying and deciphering the PI3K pathway, which has led to new treatments for several types of cancer.
By learning how contagious cancer spreads among shellfish, scientists hope to better understand how cancer metastasizes in people.
- March 19, 2015
At a special event at Columbia, oncologists and scientists will discuss how new research is changing the way cancer is being treated.
- March 16, 2015
At Columbia, every pediatric cancer patient’s tumor is sequenced, so personalized treatment may be considered.
- March 12, 2015
Advances in how the immune system can be harnessed to fight cancer offer new hope to patients with lung cancer.
- February 26, 2015
Director of the National Cancer Institute, Harold Varmus, MD'66, talked about the challenges and goals of precision medicine's efforts to tackle cancer.
- February 23, 2015
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care.
- February 19, 2015
An article in Cancer Today describes how the film based on Siddhartha Mukherjee's book came about.
- February 5, 2015
Three-part, six-hour documentary is based on Mukherjee’s Pulitzer Prize-winning "The Emperor of All Maladies: A Biography of Cancer."
- January 30, 2015
Two Columbia University Medical Center faculty members were present today when President Obama provided details of the precision medicine initiative he announced during this year’s State of the Union address.
- January 20, 2015
Azra Raza, an internationally known specialist in the blood disorder myelodysplastic syndrome, sees patients who travel from all over the country to receive the latest therapies and to participate in research studies for this relatively rare condition.